Inotuzumab ozogamicin and Insulin aspart protamine and insulin aspart Subcutaneous
Determining the interaction of Inotuzumab ozogamicin and Insulin aspart protamine and insulin aspart Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab Ozogamicin
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: Insulin aspart and insulin aspart protamine, Insulin Aspart Protamine and Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Inotuzumab ozogamicin-Insulin Aspart Protamine and Insulin Aspart (Vials)
- Inotuzumab ozogamicin-Insulin Aspart Protamine Injection
- Inotuzumab ozogamicin-Insulin aspart, recombinant Subcutaneous
- Inotuzumab ozogamicin-Insulin degludec
- Inotuzumab ozogamicin-Insulin Degludec (U-100) Prefilled Pens
- Insulin aspart protamine and insulin aspart Subcutaneous-Inotuzumab ozogamicin Intravenous
- Insulin aspart protamine and insulin aspart Subcutaneous-Inova
- Insulin aspart protamine and insulin aspart Subcutaneous-Inova 4/1 topical
- Insulin aspart protamine and insulin aspart Subcutaneous-Inova 8/2 topical
- Insulin aspart protamine and insulin aspart Subcutaneous-Inova ACT
- Insulin aspart protamine and insulin aspart Subcutaneous-Inrebic